Jabra Enhance Plus vs Resound Vivia 9 60S microRIE

The Jabra Enhance Plus is a mid-priced OTC hearing aid ($799) that earns a B grade with a SoundScore of 3.8/5 in our lab testing, ranking #28 of 65 devices in the OTC category. This visible-in-ear device delivers strong speech-in-quiet performance, scoring 4.2/5—a full 1.36 points above the category average. Music streaming is another highlight at 3.8/5, nearly 1.9 points above average, making it a solid choice for users who value audio quality beyond speech. Speech-in-noise performance scores 2.1/5, which is above the category average by 0.62 points but remains mixed in absolute terms for challenging listening environments. The most significant limitation is own-voice comfort, scoring just 0.3/5—well below the category average of 2.51/5. Users sensitive to how their own voice sounds while wearing hearing aids should consider this trade-off carefully. Feedback handling is excellent at 4.7/5, meaning wearers can expect stable performance without whistling or squealing. The Jabra Enhance Plus is best suited for users who prioritize clear speech in quieter settings and enjoy streaming music or calls to their iPhone. Those frequently in noisy environments or particularly bothered by occlusion effects may want to explore alternatives. Several competitors in the same price range achieve higher overall scores, including the Sony CRE-E10 and Lexie B2 Plus.

The Resound Vivia 9 60S microRIE is a premium prescription behind-the-ear hearing aid released in 2025, currently available at $3,798. In HearAdvisor's lab testing, it earned a B grade with a SoundScore of 3.9/5, ranking #27 of 36 prescription hearing aids tested. This device demonstrates a mixed performance profile in our testing. Own-voice comfort is a notable strength, scoring 3.4/5—a solid result that sits 0.65 points above the category average, which may appeal to users sensitive to the hollow or boomy sound of their own speech. Speech clarity in quiet environments also performs well at 3.4/5, slightly above the category average. However, the Vivia 9 shows significant limitations in challenging listening situations. Speech in noise scored just 1.1/5, falling 0.81 points below the prescription hearing aid average—a substantial gap that suggests difficulty in restaurants, group conversations, or other noisy environments. Feedback handling, while strong in absolute terms at 4.2/5, still lands 0.51 points below what we typically see from prescription devices. Music streaming quality is mixed at 2.6/5, essentially matching the category average. At this premium price point, the Vivia 9 faces stiff competition. Several same-priced alternatives, including the Phonak Sphere Infinio and Oticon Intent, achieved notably higher overall scores in our testing. Consumers prioritizing noise performance may want to explore these options or consider lower-priced alternatives like the Sennheiser All Day Clear that delivered stronger overall results in our lab.